Total Payments
$6,447
2024 Payments
$730.88
Companies
51
Transactions
334
Medicare Patients
7,825
Medicare Billing
$712,992
Payment Breakdown by Category
Food & Beverage$6,092 (94.5%)
Education$355.07 (5.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,092 | 327 | 94.5% |
| Education | $355.07 | 7 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,197 | 73 | $0 (2024) |
| Medtronic, Inc. | $506.50 | 21 | $0 (2024) |
| Medtronic USA, Inc. | $457.43 | 24 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $353.48 | 20 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $351.39 | 24 | $0 (2023) |
| COLOPLAST CORP | $311.11 | 14 | $0 (2024) |
| 180 Medical, Inc. | $262.24 | 12 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $257.09 | 17 | $0 (2022) |
| Allergan, Inc. | $241.35 | 16 | $0 (2021) |
| Blue Earth Diagnostics Limited | $237.12 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.88 | 34 | Sumitomo Pharma America, Inc. ($200.53) |
| 2023 | $779.68 | 40 | Medtronic, Inc. ($223.43) |
| 2022 | $750.04 | 42 | Astellas Pharma US Inc ($173.66) |
| 2021 | $733.40 | 46 | Astellas Pharma US Inc ($151.65) |
| 2020 | $813.67 | 42 | Medtronic USA, Inc. ($171.93) |
| 2019 | $773.75 | 38 | Medtronic USA, Inc. ($175.04) |
| 2018 | $996.49 | 47 | CONMED Corporation ($142.49) |
| 2017 | $868.69 | 45 | Astellas Pharma US Inc ($297.93) |
All Payment Transactions
334 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: HORMONE THERAPY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: HORMONE THERAPY | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: HORMONE THERAPY | ||||||
| 11/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/06/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: CONTINENCE CARE | ||||||
| 10/30/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/23/2024 | Laborie Medical Technologies Corp. | EndoSheath Technology (Device) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Urology | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: UROLOGY | ||||||
| 09/09/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: CONTINENCE CARE | ||||||
| 09/06/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.76 | General |
| Category: UROLOGY | ||||||
| 08/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: HORMONE THERAPY | ||||||
| 07/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: UROLOGY | ||||||
| 07/08/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 07/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: HORMONE THERAPY | ||||||
| 06/27/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $101.38 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/27/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/17/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $29.29 | General |
| 05/30/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Urology Gynecology | ||||||
| 05/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/16/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Urology Gynecology | ||||||
| 04/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/09/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,780 | 2,369 | $549,650 | $177,426 |
| 2022 | 20 | 1,877 | 2,509 | $463,315 | $160,401 |
| 2021 | 27 | 2,494 | 3,714 | $693,915 | $241,705 |
| 2020 | 25 | 1,674 | 2,290 | $380,145 | $133,460 |
Total Patients
7,825
Total Services
10,882
Medicare Billing
$712,992
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 426 | 614 | $123,300 | $57,860 | 46.9% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 74 | 74 | $66,600 | $22,806 | 34.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 253 | $32,890 | $16,235 | 49.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 96 | $72,000 | $12,964 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 187 | $28,050 | $12,593 | 44.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 76 | 80 | $20,000 | $8,478 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $17,700 | $6,988 | 39.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 96 | 99 | $40,400 | $6,405 | 15.9% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 12 | 12 | $19,200 | $5,330 | 27.8% |
| 51705 | Simple change of bladder tube | Office | 2023 | 14 | 67 | $11,725 | $5,267 | 44.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 22 | 22 | $7,700 | $3,387 | 44.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 25 | 28 | $28,000 | $3,234 | 11.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 23 | 47 | $8,225 | $2,168 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,500 | $2,147 | 33.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 29 | 29 | $4,640 | $1,984 | 42.8% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 65 | 65 | $19,500 | $1,672 | 8.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 147 | 163 | $8,150 | $1,364 | 16.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $4,200 | $1,276 | 30.4% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 11 | 11 | $6,050 | $1,181 | 19.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 204 | 244 | $2,440 | $958.20 | 39.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 54 | $2,430 | $901.60 | 37.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 11 | 12 | $1,800 | $739.92 | 41.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 17 | $1,700 | $432.32 | 25.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 74 | 74 | $9,250 | $427.04 | 4.6% |
| 76856 | Complete ultrasound scan of pelvis | Facility | 2023 | 12 | 12 | $3,000 | $320.40 | 10.7% |
About Dr. Anil Kumar, MD
Dr. Anil Kumar, MD is a Urology healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073619615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Kumar, MD has received a total of $6,447 in payments from pharmaceutical and medical device companies, with $730.88 received in 2024. These payments were reported across 334 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($6,092).
As a Medicare-enrolled provider, Kumar has provided services to 7,825 Medicare beneficiaries, totaling 10,882 services with total Medicare billing of $712,992. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Rochester Hills, MI
- Active Since 09/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1073619615
Products in Payments
- INTERSTIM (Device) $783.21
- XTANDI (Drug) $508.77
- XIAFLEX (Biological) $351.39
- ORGOVYX (Drug) $342.90
- ELIGARD (Drug) $257.09
- Axumin (Drug) $237.12
- BOTOX (Biological) $214.07
- Myrbetriq (Drug) $201.75
- Xtandi (Drug) $175.52
- GEMTESA (Drug) $148.30
- AirSeal (Device) $142.49
- MYRBETRIQ (Drug) $118.99
- MazorX - Renaissance (Device) $96.77
- iTIND System (Device) $85.45
- O-ARM-Spine (Device) $83.95
- GENTLECATH (Device) $77.29
- PENILE RECONSTRUCTION (Device) $72.75
- Envarsus XR (Drug) $70.71
- SCS IPGs (Device) $69.80
- Senza Spinal Cord Stimulation System (Device) $63.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.